Research-grade BPC-157 is sold as a laboratory chemical with no COA verification, frequently contains impurities, is often incorrectly dosed, and is not produced under any pharmaceutical quality standard
Plan selection during the next Annual Enrollment Period will be critical if you want continued GLP-1 access
You have cleaned up your diet
Insulin-like growth factor I prevents cellular aging via activation of mitophagy
Mounjaro works by activating GLP-1 and GIP receptors, which: Slows gastric emptying, so food stays in the stomach longer and you feel full sooner Reduces appetite and food cravings by acting on hunger signals in the brain Improves insulin release from the pancreas in response to meals Lowers glucagon secretion, which reduces how much sugar the liver releases into the blood The combined effect is better blood sugar (glucose) control and a natural reduction in calorie intake, which is what drives the weight loss seen in clinical studies
Your healthcare provider will monitor kidney function and adjust doses if needed, as both medications require renal consideration at different thresholds
